AMO Pharma: Encouraging Phase II Results for Congenital and Juvenile Myotonic Trial.
AMO Pharma has announced results from its ongoing phase II study investigating two doses of tideglusib (AMO-02) in adults with congenital...
Visibility is Not Inclusion
I’ve learned a lot over the years. Perhaps the hardest lesson is that visibility of disabled people has never equalled inclusion. I’m a...
Muscle Owl Talks Ep69: No Wheelchair on the First Day of School?!
Today is World Duchenne Awareness Day. It was also 4 year old Fraser's first day of school! However Fraser - who unlike many with DMD,...
Muscle Owl Talks Ep68: World Duchenne Awareness Day with Jon Hastie
Tune in to the first of our two special episodes for World Duchenne Awareness Day! We are joined by our friend and regular guest Jon...
World Duchenne Awareness Day 2017 - Our Community's Balloons!
It’s World Duchenne Awareness Day 2017! Here is our annual Duchenne Awareness Day animation, featuring facts about the condition, and ALL...
Muscle Owl Talks Ep67: Duchenne - Just Children?
Duchenne muscular dystrophy.... A childhood condition? After reading a number of posts from around the community, Peter and Vivek respond...
